WHO ICTRP trial
The predictive value of the APOA-1/HDL ratio for the severity and clinical…
ChiCTR2500113937 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500113937 |
|---|---|
| Public title | The predictive value of the APOA-1/HDL ratio for the severity and clinical outcomes of patients with severe community-acquired pneumonia: A single-center prospective observational study |
| Scientific title | The predictive value of the APOA-1/HDL ratio for the severity and clinical outcomes of patients with severe community-acquired pneumonia: A single-center prospective observational study |
| Primary sponsor | Shanghai General Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | 0 |
| Countries | China |
| Conditions | Community-acquired pneumonia, cough with expectoration, fever |
| Interventions | Case series :NA |
| Registration date | Dec 4, 2025 |
| Target size | Case series :200 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: